Abstract
3 years after the first identified case of the Middle East respiratory syndrome coronavirus (MERS-CoV) infection, no specific treatment with proven effectiveness exists. More than 1600 people infected with the virus from 26 countries have been reported to WHO, including more than 600 related deaths.1 As a result of a large hospital outbreak at King Abdulaziz Medical City, Riyadh, Saudi Arabia,2 between August and September, 2015, the Saudi Arabian Ministry of National Guard Health Affairs organised a 2 day research initiative workshop on Sept 9–10, 2015, to make recommendations for therapeutic (panel 1) and non-therapeutic (panel 2) research on MERS-CoV.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
